- Local governmentsIncreases transparency of Medicare spending by publishing granular, machine-readable county/MSA-level monthly expenditu…
- Potential benefitProvides a standardized data foundation for comparisons of Medicare Advantage (MA) versus fee-for-service (FFS) expendi…
- Federal agenciesMay improve federal oversight and actuarial projections by requiring trustees and MedPAC to include disaggregated expen…
Apples to Apples Comparison Act of 2025
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
This bill requires the Secretary of HHS to publish, in machine-readable files on the CMS public website, county- and Metropolitan Statistical Area-level total and average Medicare expenditures (by month) broken down into many enrollment and coverage categories, beginning with 2025 and including a 10-year historical series for the initial 2025 publication. It also directs MedPAC to include, beginning in 2026, a retrospective, replicable analysis comparing average expenditures for Medicare Advantage enrollees with comparable fee-for-service (parts A and B) beneficiaries, with specified data- and methodology-transparency and public comment requirements.
Transparency vs. administrative burden: liberals see transparency as a tool for reform; conservatives emphasize increased federal workload and costs.
Relative to its intended legislative type, this bill is a purposefully detailed reporting mandate that effectively specifies what data should be published, by whom, and when, and also requires complementary analyses by MedPAC and inclusion in Trustees reports.
This bill requires the Secretary of HHS to publish, in machine-readable files on the CMS public website, county- and Metropolitan Statistical Area-level total and average Medicare expenditures (by month) broken down into many enrollment and coverage categories, beginning with 2025 and including a 10-year historical series for the initial 2025 publication.
It also directs MedPAC to include, beginning in 2026, a retrospective, replicable analysis comparing average expenditures for Medicare Advantage enrollees with comparable fee-for-service (parts A and B) beneficiaries, with specified data- and methodology-transparency and public comment requirements.
The Boards of Trustees for the Hospital Insurance and Supplementary Medical Insurance Trust Funds must begin including aggregate and average expenditure information by beneficiary category in their annual reports beginning in 2026.
On substance the bill is a narrowly focused transparency/analysis measure rather than a large entitlement change, which increases its chances relative to sweeping reforms. However, its heavy technical demands, many disaggregation requirements, and the politically sensitive comparisons between Medicare Advantage and fee-for-service create implementation and stakeholder-opposition risks. The absence of cost estimates and the need for significant CMS/MedPAC work reduce near-term likelihood without supplemental appropriations or administrative commitments.
Relative to its intended legislative type, this bill is a purposefully detailed reporting mandate that effectively specifies what data should be published, by whom, and when, and also requires complementary analyses by MedPAC and inclusion in Trustees reports. The bill is strong on statutory placement and data specificity but weak on fiscal acknowledgement and some operational safeguards.
Transparency vs. administrative burden: liberals see transparency as a tool for reform; conservatives emphasize increased federal workload and costs.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- CountiesPublishing highly granular monthly expenditure data by county/MSA and many small enrollment subgroups could increase ri…
- Federal agenciesImplementing, maintaining, and securing the new machine-readable data releases and the required analytic and publicatio…
- Potential burdenPublic, granular expenditure data may be misinterpreted or used out of context (for example, without full risk-adjustme…
Why the argument around this bill splits.
Transparency vs. administrative burden: liberals see transparency as a tool for reform; conservatives emphasize increased federal workload and costs.
A mainstream liberal would likely view the bill favorably as a transparency and accountability measure that enables clearer comparison of Medicare Advantage versus traditional Medicare and geographic variation in spending.
They would see the data publication and MedPAC analysis as tools to identify overpayments, disparities, and opportunities to improve equity and program integrity.
This persona would emphasize the potential to inform policy reforms to reallocate funds or strengthen benefits for underserved areas.
A centrist/moderate would generally view the bill as a pragmatic transparency and analytic improvement that could strengthen evidence for policy decisions while seeking assurances about costs, methodology, and privacy.
They would appreciate the public, machine-readable requirement and the built-in public comment process for MedPAC methodology, but would be cautious about implementation burdens and unintended consequences.
This persona would weigh benefits for oversight and fiscal planning against the operational cost to CMS and the need to protect individual confidentiality.
A mainstream conservative would have mixed to skeptical views: some would welcome more transparency on federal spending, but many would worry the bill increases federal administrative burdens, risks data misuse, and could be used to justify increased regulation of Medicare Advantage.
They would be concerned about expanded federal data collection and potential privacy issues and might view MedPAC’s mandated comparison language (e.g., not counting favorable selection differences) as prescriptive and likely to be used to argue for reducing MA plan payments.
Overall, conservatives would seek limits on scope, costs, and downstream regulatory consequences.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On substance the bill is a narrowly focused transparency/analysis measure rather than a large entitlement change, which increases its chances relative to sweeping reforms. However, its heavy technical demands, many disaggregation requirements, and the politically sensitive comparisons between Medicare Advantage and fee-for-service create implementation and stakeholder-opposition risks. The absence of cost estimates and the need for significant CMS/MedPAC work reduce near-term likelihood without supplemental appropriations or administrative commitments.
- No cost estimate or appropriation authority in the text — it is unclear whether CMS and other agencies would have sufficient funding or staff to meet the new reporting and analysis mandates without additional resources.
- Practical feasibility and data quality: producing monthly, county/MSA-level, multi-year, multi-category expenditure data while protecting individual confidentiality is technically challenging; the degree to which existing CMS data systems can support this is unspecified.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Transparency vs. administrative burden: liberals see transparency as a tool for reform; conservatives emphasize increased federal workload…
On substance the bill is a narrowly focused transparency/analysis measure rather than a large entitlement change, which increases its chanc…
Relative to its intended legislative type, this bill is a purposefully detailed reporting mandate that effectively specifies what data should be published, by whom, and when, and also requires complementary analyses by…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.